These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2987112)

  • 21. Suppressor alveolar macrophages in experimentally induced uremia.
    Alevy YG; Hutcheson P; Mueller KR; Slavin RG
    J Reticuloendothel Soc; 1983 Jan; 33(1):11-20. PubMed ID: 6572723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of hemodialysis and transplantation on inhibition of lymphocyte transformation by sera from uremic patients.
    Nelson DS; Penrose JM
    Clin Immunol Immunopathol; 1975 May; 4(1):143-6. PubMed ID: 1092497
    [No Abstract]   [Full Text] [Related]  

  • 23. Induction of suppressor cell activity in normal peripheral blood mononuclear cells by sera from predialytic uremic patients.
    Modai D; Berman S; Weissgarten J; Klinovsky E; Cohn M; Averbukh Z
    Int Arch Allergy Appl Immunol; 1990; 92(3):268-71. PubMed ID: 2148928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Humoral inhibitors of the immune response in uremia. IV. Effects of serum and of isolated serum very low density lipoprotein from uremic rats on cellular immune reactions in vitro.
    Raskova J; Raska K
    Lab Invest; 1981 Nov; 45(5):410-7. PubMed ID: 6457930
    [No Abstract]   [Full Text] [Related]  

  • 25. Is uremia immunosuppressive in renal transplantation?
    Häyry P; von Willebrand E; Taskinen E; Höckerstedt K; Ahonen J; Eklund B
    Transplantation; 1982 Nov; 34(5):268-72. PubMed ID: 6760482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of varying dialysis regimens on lymphocyte stimulation.
    Hurst KS; Saldanha LF; Steinberg SM; Galen MA; Lowrie EG; Gagneux SA; Lazarus JM; Strom TB; Carpenter CB; Merrill JP
    Trans Am Soc Artif Intern Organs; 1975; 21():329-34. PubMed ID: 1146004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of insulin resistance in normal adipose tissue by uremic human serum.
    McCaleb ML; Mevorach R; Freeman RB; Izzo MS; Lockwood DH
    Kidney Int; 1984 Feb; 25(2):416-21. PubMed ID: 6374254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunosuppressive effect of soluble E receptors in uremic serum.
    Musatti CC; Soares VA; Santos LM; De Lima JJ; Mendes NF
    Clin Immunol Immunopathol; 1979 Dec; 14(4):403-10. PubMed ID: 159794
    [No Abstract]   [Full Text] [Related]  

  • 29. Zinc-induced enhancement of lymphocyte function and viability in chronic uremia.
    Antoniou LD; Shalhoub RJ
    Nephron; 1985; 40(1):14-21. PubMed ID: 3873624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An immunosuppressive factor(s) in uremic sera.
    Kamata K; Okubo M; Marumo F
    Proc Clin Dial Transplant Forum; 1980; 10():47-50. PubMed ID: 6981113
    [No Abstract]   [Full Text] [Related]  

  • 31. Binding of organic acids to surface receptors of lymphocytes as an immunosuppressive mechanism in uremia.
    Sanaka T; Hayasaka Y; Kawashima Y; Takuma T; Sugino N; Ota K; Gulyassy PF
    Adv Exp Med Biol; 1987; 223():165-9. PubMed ID: 3502315
    [No Abstract]   [Full Text] [Related]  

  • 32. Humoral inhibitors of the immune response in uremia. V. Induction of suppressor cells in vitro by uremic serum.
    Raskova J; Raska K
    Am J Pathol; 1983 May; 111(2):149-55. PubMed ID: 6221666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The ability of uremic serum to induce neutrophil chemotaxis in relation to hemodialysis.
    Pedersen JO; Knudsen F; Nielsen AH; Grunnet N
    Blood Purif; 1987; 5(1):24-8. PubMed ID: 3790268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of guanidino-propionic acid on lymphocyte proliferation.
    Shainkin-Kestenbaum R; Winikoff Y; Dvilansky A; Chaimovitz C; Nathan I
    Nephron; 1986; 44(4):295-8. PubMed ID: 3796772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A gas chromatographic-mass spectrometric analysis for phenols in uremic serum.
    Niwa T; Maeda K; Ohki T; Saito A; Kobayashi K
    Clin Chim Acta; 1981 Feb; 110(1):51-7. PubMed ID: 7214714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular immune function in uremia: altered cytotoxic and suppressor cell responses to an immunomodulating heptapeptide.
    Rola-Pleszczynski M; Bolduc D; Forand S; Plante GE; St-Pierre S
    Clin Immunol Immunopathol; 1983 Aug; 28(2):177-84. PubMed ID: 6223765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Somatomedin inhibitor in uremia.
    Phillips LS; Fusco AC; Unterman TG; del Greco F
    J Clin Endocrinol Metab; 1984 Oct; 59(4):764-72. PubMed ID: 6384255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of humoral and cellular factors that contribute to impaired immune responsiveness in experimental uremia.
    Mezzano S; Pesce AJ; Pollak VE; Michael JG
    Nephron; 1984; 36(1):15-9. PubMed ID: 6606788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of [Phe(4F)3]thymopoietin II and examination of its immunological effect on the impaired blastogenic response of T-lymphocytes of uremic patients.
    Abiko T; Sekino H
    Bioorg Med Chem; 1995 Oct; 3(10):1369-75. PubMed ID: 8564403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of maintenance dialysis on lymphocyte function. I. Haemodialysis.
    Holdsworth SR; Fitzgerald MG; Hosking CS; Atkins RC
    Clin Exp Immunol; 1978 Jul; 33(1):95-101. PubMed ID: 709914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.